Medigene to Present at Upcoming Investor Conferences
October 29, 2024 06:30 ET
|
Medigene AG
Planegg/Martinsried, October 29, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...